To expand on potential pathways through which the IL-17 axis regulates macrophage recruitment, we next examined hepatic CCL22 levels, a macrophage activating chemokine which also serves as a potential marker for human NASH [33, 37]. This evidence concerns the gene CCL22 and metabolic dysfunction-associated steatohepatitis.